Products for Research Use Only
RegisterLogin

Brazikumab

CAT: 0804-HY-P99485-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99485-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Brazikumab (AMG 139) is a human IgG2 monoclonal antibody, selectively binds the p19 subunit of IL-23, with a KD of 0.138 nM for human IL-23. Brazikumab can be used for the research of Crohn's disease[1].
CAS Number
1610353-18-8
Product Name Alternative
AMG 139; MEDI2070
UNSPSC
12352203
Target
Interleukin Related
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/brazikumab.html
Purity
95.00
Solubility
H2O
Smiles
[Brazikumab]
Molecular Weight
(144.82 kDa)
References & Citations
[1]Currò D, et, al. Frontiers in Drug Research and Development for Inflammatory Bowel Disease. Front Pharmacol. 2017 Jun 23;8:400.|[2]Al-Bawardy B, et, al. Novel and Emerging Therapies for Inflammatory Bowel Disease. Front Pharmacol. 2021 Apr 14;12:651415.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Isoform
IL-23

Alternative Products

CatalogName
GTR18153871-01Brazikumab
GTR18337837-01Brazikumab Antibody
591722Brazikumab (IL23A)
E55B0263Brazikumab (Reference antibody)
WA2546Research Grade Brazikumab
KBI1201KRIBIOLISA™ Brazikumab ELISA
ICH5413-25mgBrazikumab Biosimilar - Research Grade
C00700-1mgBrazikumab (Anti-IL-23)
ABS-364-1mgBrazikumab Biosimilar, Research Grade
GTR18698004-01Brazikumab Human Monoclonal Antibody

Popular Products